Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
Experts Warn Covid-19 Wave Looming
Experts are warning about a new Covid-19 wave as 14 of New York City's wastewater treatment plants showed high levels of the disease in the past week.
Load More